Zydus Lifesciences Limited
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Zydus Lifesciences Limited's past years’ income statements indicate that its last revenue has increased compared to the previous period by 32% to $195,474,000,000. Profit margin reached 20%. Total operating expenses were $83,105,000,000.

Profit Margin

Zydus Lifesciences Limited (NSE:ZYDUSLIFE.NS): Profit margin
2012 50.9B 6.52B 12.82%
2015 86.51B 11.48B 13.28%
2016 98.37B 15.22B 15.48%
2018 115.99B 17.75B 15.31%
2019 127.48B 18.48B 14.5%
2021 148.21B 21.33B 14.4%
2022 148.27B 44.87B 30.26%
2024 195.47B 38.59B 19.74%

ZYDUSLIFE.NS Income Statement (2012 – 2023)

2023 2021 2020 2018 2017 2015 2014 2012
Revenue
Revenue
195.47B148.27B148.21B127.48B115.99B98.37B86.51B50.9B
Cost of revenue
106.22B58.18B54.8B49.49B43.42B34.59B33.09B20.55B
Gross profit
89.24B90.08B93.41B77.98B72.56B63.77B53.41B30.34B
Operating exp.
Research and development
13.12B1.14B1.18B1.07B1.68B1.38B1.09B0
Selling and marketing
16.58B13.73B13.88B10.35B10.14B10.20B9.60B0
Total operating expenses
83.10B65.32B67.15B54.75B49.56B42.93B38.52B24.31B
Operating income
45.39B24.74B27.35B23.92B23.00B20.84B14.88B6.02B
Other income (expenses), net
2.69B4.10B-2.89B364M306M570M-434M1.91B
Income before tax
48.08B28.38B22.84B23.82B23.30B21.23B14.45B7.94B
Income tax expense
9.77B5.11B1.47B5.30B5.64B5.71B2.59B1.13B
Net income
38.59B44.87B21.33B18.48B17.75B15.22B11.48B6.52B
Earnings per share
Basic EPS
38.1417.6520.8418.0617.3519.1911.246.37
Diluted EPS
38.1417.6520.8418.0617.3519.1911.246.37
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData source